A61K 38/1709
From mammals
Official title: {from mammals}
A61K38/1709 (From mammals) appears on 4,756 US grants and 9,064 published applications in this corpus.
Search patents in A61K- Granted patents
- 4,756
- Published applications
- 9,064
- Assignees
- 3,076
- Inventors
- 14,113
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 5 | 0 |
| 1979 | 0 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 3 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 15 | 0 |
| 1994 | 10 | 0 |
| 1995 | 9 | 0 |
| 1996 | 20 | 0 |
| 1997 | 34 | 0 |
| 1998 | 65 | 0 |
| 1999 | 75 | 0 |
| 2000 | 72 | 0 |
| 2001 | 73 | 25 |
| 2002 | 68 | 178 |
| 2003 | 67 | 268 |
| 2004 | 70 | 274 |
| 2005 | 76 | 307 |
| 2006 | 83 | 307 |
| 2007 | 84 | 300 |
| 2008 | 101 | 254 |
| 2009 | 129 | 329 |
| 2010 | 128 | 300 |
| 2011 | 156 | 357 |
| 2012 | 161 | 294 |
| 2013 | 168 | 377 |
| 2014 | 231 | 415 |
| 2015 | 254 | 452 |
| 2016 | 260 | 502 |
| 2017 | 261 | 439 |
| 2018 | 266 | 420 |
| 2019 | 322 | 435 |
| 2020 | 269 | 450 |
| 2021 | 250 | 423 |
| 2022 | 231 | 456 |
| 2023 | 182 | 380 |
| 2024 | 206 | 428 |
| 2025 | 193 | 413 |
| 2026 | 134 | 281 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions of chondrisomes6 Oct 2026US 12,751,977 B2Children's Medical Center Corporation
- Methods for treating pancreatic cancer and other solid tumors6 Oct 2026US 12,751,991 B2Lisata Therapeutics, Inc.
- Methods and compositions for treating cardiovascular diseases using fat specific protein 27 (FSP27) compositions6 Oct 2026US 12,751,992 B2Ohio University
- Application of TFF2 protein and IFN-κ protein combination in treatment of a novel coronavirus infection6 Oct 2026US 12,751,996 B2Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
- Composition for inducing direct cross differentiation of somatic cell into motor neuron, and method for using same6 Oct 2026US 12,753,385 B2Unist (Ulsan National Institute of Science and Technology)
- Concentrated milk protein preparations8 Oct 2026US 2026/0305634 A150G Inc.
- Compositions and methods for improving brain health8 Oct 2026US 2026/0306520 A1Societe des Produits Nestle S. A.
- Use of annexin v as a method to block tumor induced immunosuppression of the innate immune response8 Oct 2026US 2026/0306583 A1The Board of Trustees of the Leland Stanford Junior University
- Process and formulation of lipid nanoparticles8 Oct 2026US 2026/0306584 A1Translate Bio, Inc.
- Recombinant adeno-associated viral vectors for multipartite gene delivery and stargardt disease treatment8 Oct 2026US 2026/0306667 A1Abeona Therapeutics Inc.
Most cited
By later US patents
- Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix365US 6,309,669 B1The United States of America as represented by the Secretary of the Army · 2001
- Lipid formulation340US 8,158,601 B2Alnylam Pharmaceuticals, Inc. · 2012
- Immunotherapy against several tumors, such as lung cancer, including NSCLC198US 10,071,148 B2Immatics Biotechnologies GmbH · 2018
- Engineered nucleic acids and methods of use thereof184US 9,464,124 B2Moderna Therapeutics, Inc. · 2016
- Chemically modified novel erythropoietin stimulating protein compositions and methods170US 6,586,398 B1Amgen Inc. · 2003